Leaflet VIRACEPT 625mg film-coated tablets
Indicated for: HIV-1 infection
Route of administration: oral
Substance: nelfinavir (antiretroviral)
ATC: J05AE04 (Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Nelfinavir is an antiretroviral medication used for the treatment of HIV-1 infection. It belongs to the class of protease inhibitors and works by blocking the HIV protease enzyme, preventing viral replication.
The medication is taken orally, as directed by a doctor, usually two or three times daily with food. It is important for patients to follow the treatment regimen to prevent the development of viral resistance.
Patients should be aware of potential side effects, such as diarrhea, nausea, or abdominal pain. It is important to inform the doctor of any unusual symptoms.
Common side effects include diarrhea, nausea, and abdominal pain. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about VIRACEPT 625mg
- Substance: nelfinavir
- Date of latest medicines list: 01-07-2013
- Product code: W41752001
- Concentration: 625mg
- Pharmaceutical form: film-coated tablets
- Quantity: 120
- Product type: Original
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Pharmaceutical forms available for nelfinavir
Concentrations available for nelfinavir
- 250mg
- 50mg/g
- 625mg